Related Experiment Video
Updated: Jul 21, 2025

11:32
A Hydrogen-Deuterium Exchange Mass Spectrometry HDX-MS Platform for Investigating Peptide Biosynthetic Enzymes
Published on: May 4, 2020
8.1K
Native dynamics and allosteric responses in PTP1B probed by high-resolution HDX-MS
Virgil A Woods1,2, Rinat R Abzalimov1, Daniel A Keedy1,3,4
1Structural Biology Initiative, CUNY Advanced Science Research Center, New York, NY 10031.
Biorxiv : the Preprint Server for Biology
|July 28, 2023
Summary
Hydrogen-deuterium exchange mass spectrometry (HDX-MS) reveals protein tyrosine phosphatase 1B (PTP1B) dynamics. Inhibitor binding causes widespread allosteric changes, guiding therapeutic development for obesity and diabetes.
Area of Science:
- Biophysics
- Structural Biology
- Pharmacology
Background:
- Protein tyrosine phosphatase 1B (PTP1B) is a key therapeutic target for metabolic diseases and cancer.
- Understanding PTP1B's conformational dynamics and allostery is crucial for developing effective allosteric inhibitors.
Approach:
- Employed high-resolution hydrogen-deuterium exchange mass spectrometry (HDX-MS) to map PTP1B's solution dynamics.
- Generated HDX-MS maps for apo-PTP1B and in the presence of active-site and allosteric inhibitors.
Key Points:
- HDX-MS revealed flexible loops and distinct dynamic regions in apo-PTP1B, adding value to crystal structure-based predictions.
- Inhibitor binding induced significant, long-range alterations in PTP1B's dynamics, distinct for active-site vs. allosteric inhibitors.
- Observed allosteric effects extended over 35 Å from ligand binding sites, highlighting PTP1B's complex conformational landscape.
Conclusions:
- HDX-MS is a powerful technique for elucidating protein dynamics and allosteric mechanisms.
- Findings provide critical insights into PTP1B allostery, supporting the rational design of novel therapeutics.
- Integration of HDX-MS with other methods can accelerate the development of PTP1B-targeted drugs.

